Do you have a link to that article (no source is given)?
Interesting to see an (assumed) use of that "expanded access" program so soon after it is announced. Will the company, under those new guidelines, be allowed to charge patients for the treatment?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.